Items where authors include "Brion, R."

Article

Talbot, J., Brion, R., Lamora, A. et al. (4 more authors) (2018) Connexin43 intercellular communication drives the early differentiation of human bone marrow stromal cells into osteoblasts. Journal of Cellular Physiology, 233 (2). pp. 946-957. ISSN 0021-9541

Aubin, G.G., Baud'huin, M., Lavigne, J.P. et al. (7 more authors) (2017) Interaction of Cutibacterium (formerly Propionibacterium) acnes with bone cells: a step toward understanding bone and joint infection development. Scientific Reports, 7. 42918. ISSN 2045-2322

Chemel, M., Brion, R., Segaliny, A.I. et al. (7 more authors) (2017) Bone Morphogenetic Protein 2 and Transforming Growth Factor β1 Inhibit the Expression of the Proinflammatory Cytokine IL-34 in Rheumatoid Arthritis Synovial Fibroblasts. American Journal of Pathology, 187 (1). pp. 156-162. ISSN 0002-9440

Heymann, D. orcid.org/0000-0001-7777-0669, Hochant, M., Pecqueur, C. et al. (9 more authors) (2016) Low-dose pesticide mixture induces senescence in normal mesenchymal stem cells (MSC) and promotes tumorigenic phenotype in premalignant MSC. Stem Cell. ISSN 1066-5099

Rodriguez Calleja, L., Jacques, C., Lamoureux, F. et al. (13 more authors) (2016) ΔNp63α silences a microRNA program to aberrantly initiate a wound healing program that promotes TGFβ-induced metastasis. Cancer Research, 76 (11). pp. 3236-3251. ISSN 0008-5472

Davaine, J-M., Quillard, T., Chatelais, M. et al. (7 more authors) (2016) Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes. European Journal of Vascular and Endovascular Surgery, 51 (2). pp. 259-267. ISSN 1078-5884

Segaliny, A.I., Brion, R., Brulin, B. et al. (4 more authors) (2015) IL-34 and M-CSF form a novel heteromeric cytokine and regulate the M-CSF receptor activation and localization. Cytokine, 76 (2). pp. 170-181. ISSN 1043-4666

Cremet, L., Broquet, A., Brulin, B. et al. (7 more authors) (2015) Pathogenic potential of Escherichia coli clinical strains from orthopedic implant infections towards human osteoblastic cells. Pathogens and Disease, 73 (8). ftv065. ISSN 2049-632X

Sousa, S., Brion, R., Lintunen, M. et al. (9 more authors) (2015) Human breast cancer cells educate macrophages toward the M2 activation status. Breast Cancer Research, 17. 101. ISSN 1465-5411

Ségaliny, A.I., Mohamadi, A., Dizier, B. et al. (7 more authors) (2015) Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment. International Journal of Cancer , 137 (1). pp. 73-85. ISSN 0020-7136

Lamora, A., Mullard, M., Amiaud, J. et al. (4 more authors) (2015) Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases. Oncotarget, 6 (16). pp. 14413-14427. ISSN 1949-2553

Segaliny, A.I., Brion, R., Mortier, E. et al. (5 more authors) (2015) Syndecan-1 regulates the biological activities of interleukin-34. BBA - Molecular Cell Research , 1853 (5). pp. 1010-1021. ISSN 0167-4889

Cordova, L.A., Trichet, V., Escriou, V. et al. (10 more authors) (2015) Inhibition of osteolysis and increase of bone formation after local administration of siRNA-targeting RANK in a polyethylene particle-induced osteolysis model. Acta Biomaterialia, 13. pp. 150-158. ISSN 1742-7061

Darrieutort-Laffite, C., Boutet, M-A., Chatelais, M. et al. (4 more authors) (2014) IL-1 beta and TNF alpha Promote Monocyte Viability through the Induction of GM-CSF Expression by Rheumatoid Arthritis Synovial Fibroblasts. Mediators of Inflammation, 2014. 241840. ISSN 0962-9351

Lezot, F., Chesneau, J., Battaglia, S. et al. (5 more authors) (2014) Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignancies. BONE, 68. pp. 146-152. ISSN 8756-3282

Davaine, J-M., Quillard, T., Brion, R. et al. (10 more authors) (2014) Osteoprotegerin, Pericytes and Bone-Like Vascular Calcification Are Associated with Carotid Plaque Stability. PLoS ONE, 9 (9). e107642. ISSN 1932-6203

Gobin, B., Moriceau, G., Ory, B. et al. (5 more authors) (2014) Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models. PLoS ONE, 9 (3). e90795. ISSN 1932-6203

Talbot, J., Brion, R., Picarda, G. et al. (8 more authors) (2013) Loss of connexin43 expression in Ewing's sarcoma cells favors the development of the primary tumor and the associated bone osteolysis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1832 (4). pp. 553-564. ISSN 0925-4439

Guihard, P., Danger, Y., Brounais, B. et al. (9 more authors) (2012) Induction of Osteogenesis in Mesenchymal Stem Cells by Activated Monocytes/Macrophages Depends on Oncostatin M Signaling. Stem Cells, 30 (4). pp. 762-772. ISSN 1066-5099

Moriceau, G., Roelofs, A.J., Brion, R. et al. (4 more authors) (2012) Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth. Cancer, 118 (3). pp. 750-760. ISSN 0008-543X

Chemel, M., Le Goff, B., Brion, R. et al. (10 more authors) (2012) Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients. Annals of the Rheumatic Diseases (ARD), 71 (1). pp. 150-154. ISSN 0003-4967

Baud'Huin, M., Charrier, C., Bougras, G. et al. (4 more authors) (2012) Proteoglycans and osteolysis. Proteoglycans, 836. pp. 323-337. ISSN 1064-3745

Rousseau, J., Escriou, V., Lamoureux, F. et al. (8 more authors) (2011) Formulated siRNAs Targeting Rankl Prevent Osteolysis and Enhance Chemotherapeutic Response in Osteosarcoma Models. Journal of Bone and Mineral Research, 26 (10). pp. 2452-2462. ISSN 0884-0431

Benslimane-Ahmim, Z., Heymann, D. orcid.org/0000-0001-7777-0669, Dizier, B. et al. (9 more authors) (2011) Osteoprotegerin, a new actor in vasculogenesis, stimulates endothelial colony-forming cells properties. Journal of Thrombosis and Haemostasis, 9 (4). pp. 834-843. ISSN 1538-7933

Moriceau, G., Ory, B., Mitrofan, L. et al. (11 more authors) (2010) Zoledronic Acid Potentiates mTOR Inhibition and Abolishes the Resistance of Osteosarcoma Cells to RAD001 (Everolimus): Pivotal Role of the Prenylation Process. Cancer Research, 70 (24). pp. 10329-10339. ISSN 0008-5472

Baud'Huin, M., Renault, R., Charrier, C. et al. (6 more authors) (2010) Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis. Journal of Pathology, 221 (1). pp. 77-86. ISSN 0022-3417